Begin typing your search...
Showing results for "#US health regulator"
Biocon gets USFDA nod for generic anti-cancer drug
The approval will further strengthen the company’s portflolio of vertically integrated, complex drug products, it added.
The approval will further strengthen the company’s portflolio of vertically integrated, complex drug products, it added.